The Center Mr Scanners Contact Us Diagnostic Imaging Services Patient Information Referring Physicians Site Diagnostic Services Research McLean Imaging Center Applied Neuroimaging Statistics Laboratory CCNC fNIBI MIND Neurodevelopmental Lab on Addictions and Mental Health (NLAMH) Opto-Magnetic Group (OMG) Translational Imaging Translational Imaging Collaborations—Mclean Publications Publications Education N.I.D.A. T32 N.I.H. K Awards Northeastern CoOp MRI Techonlogist Training  


The MIND program, directed by Dr. Staci Gruber, is designed to examine the unique and synergistic effects of cannabis and its constituents to determine the efficacy of cannabinoids for specific conditions and diseases and to clarify the overall impact of cannabinoid treatment on physical and mental health. Despite these rapid changes in the law, many policy makers, consumers, physicians, and the general public remain misinformed about cannabis. The MIND program aims to close the gap between policy and science by utilizing cognitive and clinical assessments, as well as multimodal neuroimaging techniques. The MIND�s mission is to harness the therapeutic potential while minimizing harms of cannabinoid-based treatment in order to improve patients� overall wellbeing. The MIND program supports a number of projects which evaluate commercially available and custom-formulated cannabinoid-based therapies for a range of conditions using longitudinal, observational, cross-sectional, survey, and clinical trial models

For more information about the MIND program, please click here